BIOMAT Database Logo BIOMAT Database Logo

Identification of a specific HLA class II haplotype strongly associated with susceptibility to cyclosporine-dependent aplastic anemia. 1994

S Nakao, and H Takamatsu, and T Chuhjo, and M Ueda, and S Shiobara, and T Matsuda, and T Kaneshige, and H Mizoguchi
Third Department of Medicine, Kanazawa University School of Medicine, Japan.

Hematopoietic function of some aplastic anemia (AA) patients is dependent on the administration of cyclosporine (CyA). To investigate whether certain HLA class II genes are associated with susceptibility to such CyA-dependent AA, we determined the HLA class II alleles of 59 AA patients treated with CyA. Among 26 patients successfully treated with CyA, 13 required a small dose of CyA to maintain stable hematopoiesis. Of these 13 AA patients, 10 shared an HLA class II haplotype of DRB1*1501-DQA1*0102-DQB1*0602. None of the 13 responders who obtained a sustained remission off CyA therapy possessed this haplotype. In the 10 patients who shared the HLA class II haplotype, single-strand conformation polymorphism analysis of each gene fragment of this haplotype failed to detect a polymorphism in the nucleotide sequence. When the AA patients were assessed for their likelihood to respond to CyA therapy, the response rate in patients with this haplotype (71%) was significantly higher than that of patients with another haplotype associated with HLA-DR2, DRB1*1502-DQA1*0103-DQB1*0601 (36%) and that of patients without HLA-DR2 (35%). These findings indicate that the CyA-dependent response of AA is closely related to an HLA class II haplotype of DRB1*1501-DQA1*0102-DQB1*0602 and suggest that, in AA patients with this haplotype, immune mechanisms play an important role in the pathogenesis of bone marrow failure.

UI MeSH Term Description Entries
D007564 Japan A country in eastern Asia, island chain between the North Pacific Ocean and the Sea of Japan, east of the Korean Peninsula. The capital is Tokyo. Bonin Islands
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D012074 Remission Induction Therapeutic act or process that initiates a response to a complete or partial remission level. Induction of Remission,Induction, Remission,Inductions, Remission,Remission Inductions
D005260 Female Females
D005802 Genes, MHC Class II Genetic loci in the vertebrate major histocompatibility complex that encode polymorphic products which control the immune response to specific antigens. The genes are found in the HLA-D region in humans and include H-2M, I-A, and I-E loci in mice. Class II Genes,Genes, Class II,Genes, HLA Class II,MHC Class II Genes,Class II Gene,Gene, Class II
D006239 Haplotypes The genetic constitution of individuals with respect to one member of a pair of allelic genes, or sets of genes that are closely linked and tend to be inherited together such as those of the MAJOR HISTOCOMPATIBILITY COMPLEX. Haplotype
D006683 HLA-DQ Antigens A group of the D-related HLA antigens found to differ from the DR antigens in genetic locus and therefore inheritance. These antigens are polymorphic glycoproteins comprising alpha and beta chains and are found on lymphoid and other cells, often associated with certain diseases. HLA-DC Antigens,HLA-MB Antigens,HLA-DC,HLA-DQ,HLA-DS,HLA-DS Antigens,HLA-LB,HLA-LB Antigens,HLA-MB,Antigens, HLA-DC,Antigens, HLA-DQ,Antigens, HLA-DS,Antigens, HLA-LB,Antigens, HLA-MB,HLA DC Antigens,HLA DQ Antigens,HLA DS Antigens,HLA LB Antigens,HLA MB Antigens
D006684 HLA-DR Antigens A subclass of HLA-D antigens that consist of alpha and beta chains. The inheritance of HLA-DR antigens differs from that of the HLA-DQ ANTIGENS and HLA-DP ANTIGENS. HLA-DR,Antigens, HLA-DR,HLA DR Antigens

Related Publications

S Nakao, and H Takamatsu, and T Chuhjo, and M Ueda, and S Shiobara, and T Matsuda, and T Kaneshige, and H Mizoguchi
HLA class II RFLPs are haplotype-specific.
January 1986, Cold Spring Harbor symposia on quantitative biology,
S Nakao, and H Takamatsu, and T Chuhjo, and M Ueda, and S Shiobara, and T Matsuda, and T Kaneshige, and H Mizoguchi
Association of HLA class II (-DRB1,-DQB1,-DPB1) alleles and haplotypes on susceptibility to aplastic anemia in northern Chinese Han.
December 2020, Human immunology,
S Nakao, and H Takamatsu, and T Chuhjo, and M Ueda, and S Shiobara, and T Matsuda, and T Kaneshige, and H Mizoguchi
HLA-class II haplotype associations with ovarian cancer.
December 2006, International journal of cancer,
S Nakao, and H Takamatsu, and T Chuhjo, and M Ueda, and S Shiobara, and T Matsuda, and T Kaneshige, and H Mizoguchi
HLA DR2: a predictive marker in response to cyclosporine therapy in aplastic anemia.
October 1997, International journal of hematology,
S Nakao, and H Takamatsu, and T Chuhjo, and M Ueda, and S Shiobara, and T Matsuda, and T Kaneshige, and H Mizoguchi
Recombination sites in the HLA class II region are haplotype dependent.
August 1988, Journal of immunology (Baltimore, Md. : 1950),
S Nakao, and H Takamatsu, and T Chuhjo, and M Ueda, and S Shiobara, and T Matsuda, and T Kaneshige, and H Mizoguchi
The frequency of HLA class I and II alleles in Pakistani patients with aplastic anemia.
January 2009, Immunological investigations,
S Nakao, and H Takamatsu, and T Chuhjo, and M Ueda, and S Shiobara, and T Matsuda, and T Kaneshige, and H Mizoguchi
Class I HLA is associated with age-at-onset of IDDM, while class II HLA confers susceptibility to IDDM.
December 1995, Diabetologia,
S Nakao, and H Takamatsu, and T Chuhjo, and M Ueda, and S Shiobara, and T Matsuda, and T Kaneshige, and H Mizoguchi
HLA class II polymorphism and genetic susceptibility to insulin-dependent diabetes mellitus.
January 1990, Current topics in microbiology and immunology,
S Nakao, and H Takamatsu, and T Chuhjo, and M Ueda, and S Shiobara, and T Matsuda, and T Kaneshige, and H Mizoguchi
HLA class II sequences and genetic susceptibility to insulin dependent diabetes mellitus.
September 1991, Bailliere's clinical endocrinology and metabolism,
S Nakao, and H Takamatsu, and T Chuhjo, and M Ueda, and S Shiobara, and T Matsuda, and T Kaneshige, and H Mizoguchi
Susceptibility to aplastic anemia is associated with HLA-DRB1*1501 in an aboriginal population in Sabah, Malaysia.
October 2011, Human immunology,
Copied contents to your clipboard!